Related Experiment Video
Updated: Oct 11, 2025

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics
Published on: September 19, 2016
Endothelial SIRT1 as a Target for the Prevention of Arterial Aging: Promises and Challenges
Musammat Kulsuma Begum1,2, Daniels Konja1,2, Sandeep Singh1,2
1The State Key Laboratory of Pharmaceutical Biotechnology.
Abstract:
SIRT1, a member of the sirtuin family of longevity regulators, possesses potent activities preventing vascular aging. The expression and function of SIRT1 in endothelial cells are downregulated with age, in turn causing early vascular aging and predisposing various vascular abnormalities. Overexpression of SIRT1 in the vascular endothelium prevents aging-associated endothelial dysfunction and senescence, thus the development of hypertension and atherosclerosis. Numerous efforts have been directed to increase SIRT1 signaling as a potential strategy for different aging-associated diseases. However, the complex mechanisms underlying the regulation of SIRT1 have posed a significant challenge toward the design of specific and effective therapeutics. This review aimed to provide a summary on the regulation and function of SIRT1 in the vascular endothelium and to discuss the different approaches targeting this molecule for the prevention and treatment of age-related cardiovascular and cerebrovascular diseases.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Regulation of Angiogenesis and Blood Supply
Atherosclerosis I: Introduction
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Hypertension II: Pathophysiology

